Income Statement - Nurix Therapeutics, Inc. (NRIX)
$(Billion, Million)| Nov-25 | Nov-24 | Nov-23 | Nov-22 | Nov-21 | Nov-20 | Nov-19 | Nov-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 83.98 | 54.55 | 76.99 | 38.63 | 29.75 | 17.82 | 31.12 | 37.45 |
| Cost of revenue | 18.86 | 221.63 | 189.15 | 10.81 | 6.08 | 66.49 | 45.03 | 40.51 |
| Gross profit | 65.12 | -167.08 | -112.16 | 38.63 | 29.75 | 17.82 | -13.91 | -3.07 |
| Total operating expenses | 350.79 | 45.94 | 42.90 | 222.49 | 147.64 | 82.80 | 8.33 | 6.67 |
| Operating income | -285.67 | -213.03 | -155.06 | -183.87 | -117.89 | -64.98 | -22.24 | -9.74 |
| Non-operating income (net) | 21.97 | 19.73 | 11.12 | 3.51 | 0.82 | 1.21 | 0.78 | 0.82 |
| Income before tax | -263.70 | -193.30 | -143.95 | -180.36 | -117.06 | -63.78 | -21.46 | -8.92 |
| Income tax expense | 0.76 | 0.27 | 13.49 | -14.32 | 0.13 | -20.54 | 0.24 | 0.51 |
| Net income | -264.46 | -193.57 | -143.95 | -166.05 | -117.19 | -43.24 | -21.70 | -9.43 |
Show Quarterly Income Statement
Income Statement - Nurix Therapeutics, Inc. (NRIX)
$(Billion, Million)| Feb-26 | Nov-25 | Aug-25 | May-25 | Feb-25 | Nov-24 | Aug-24 | May-24 | Feb-24 | Nov-23 | Aug-23 | May-23 | Feb-23 | Nov-22 | Aug-22 | May-22 | Feb-22 | Nov-21 | Aug-21 | May-21 | Feb-21 | Nov-20 | Aug-20 | May-20 | Feb-20 | Nov-19 | Aug-19 | May-19 | Feb-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.25 | 13.58 | 7.89 | 44.06 | 18.45 | 13.28 | 12.59 | 12.09 | 16.59 | 15.16 | 18.47 | 30.68 | 12.69 | 6.78 | 10.79 | 11.43 | 9.62 | 7.40 | 10.25 | 7.09 | 5.01 | 6.69 | 4.09 | 4.18 | 2.86 | 1.86 | 10.58 | 9.44 | 9.23 |
| Cost of revenue | 84.14 | 4.63 | 5.00 | 78.10 | 69.66 | 67.22 | 55.48 | 48.92 | 50.01 | 49.71 | 47.86 | 45.76 | 45.82 | 46.11 | 47.76 | 47.49 | 43.14 | 36.53 | 30.91 | 25.99 | 23.00 | 20.45 | 18.94 | 14.14 | 12.97 | 12.82 | 11.01 | 10.76 | 10.43 |
| Gross profit | -77.89 | 8.95 | 2.89 | -34.04 | -51.21 | -53.94 | -42.89 | -36.83 | -33.42 | -34.55 | -29.39 | -15.09 | -33.13 | -39.32 | -36.97 | -36.06 | -33.52 | -29.14 | -20.65 | -18.90 | -17.99 | -13.76 | -14.85 | -9.96 | -10.10 | -10.96 | -0.43 | -1.32 | -1.20 |
| Total operating expenses | 14.61 | 92.04 | 94.28 | 14.28 | 11.65 | 10.72 | 11.72 | 11.71 | 11.80 | 10.78 | 10.62 | 11.68 | 9.82 | 9.37 | 9.75 | 9.65 | 9.23 | 8.82 | 8.34 | 7.51 | 6.53 | 6.25 | 4.34 | 3.27 | 2.45 | 2.60 | 2.18 | 1.87 | 1.67 |
| Operating income | -92.50 | -83.10 | -91.39 | -48.32 | -62.86 | -64.66 | -54.61 | -48.54 | -45.22 | -45.33 | -40.01 | -26.77 | -42.95 | -48.69 | -46.72 | -45.72 | -42.74 | -37.95 | -29.00 | -26.41 | -24.52 | -20.01 | -19.19 | -13.23 | -12.55 | -13.56 | -2.61 | -3.19 | -2.87 |
| Non-operating income (net) | 5.32 | 4.87 | 4.96 | 5.62 | 6.51 | 6.12 | 5.74 | 4.08 | 3.79 | 3.38 | 3.03 | 2.49 | 2.22 | 1.97 | 1.01 | 0.31 | 0.21 | 0.30 | 0.04 | 0.17 | 0.32 | 0.14 | 0.68 | 0.22 | 0.17 | 0.26 | 0.20 | 0.13 | 0.19 |
| Income before tax | -87.17 | -78.22 | -86.42 | -42.70 | -56.35 | -58.54 | -48.87 | -44.46 | -41.43 | -41.96 | -36.98 | -24.28 | -40.73 | -46.72 | -45.71 | -45.40 | -42.53 | -37.66 | -28.96 | -26.24 | -24.20 | -19.87 | -18.52 | -13.01 | -12.38 | -13.31 | -2.42 | -3.06 | -2.68 |
| Income tax expense | 0.76 | 0.01 | 0.08 | 0.09 | 0.09 | 7.89 | 3.42 | -2.49 | -5.40 | -5.01 | -1.01 | -0.31 | -0.21 | 0.04 | -0.12 | 0.14 | 0.07 | 0.04 | -0.68 | -20.59 | 0.01 | 0.21 | 0.01 | 0.01 | 0.01 | ||||
| Net income | -87.17 | -78.22 | -86.42 | -43.46 | -56.35 | -58.55 | -48.96 | -44.55 | -41.52 | -41.96 | -36.98 | -24.28 | -40.73 | -46.72 | -45.71 | -45.40 | -42.53 | -37.70 | -28.84 | -26.38 | -24.28 | -19.91 | -18.52 | 7.58 | -12.39 | -13.52 | -2.43 | -3.07 | -2.69 |